overview
RADICAVA® (edaravone) is the only FDA-approved treatment option for amyotrophic lateral sclerosis (ALS) in the last 20 years.
Mitsubishi Tanabe Pharma America
RADICAVA® (edaravone) is the only FDA-approved treatment option for amyotrophic lateral sclerosis (ALS) in the last 20 years.